Reply
- 1 January 2021
- journal article
- letter
- Published by Elsevier BV in Gastroenterology
- Vol. 160 (1), 474-475
- https://doi.org/10.1053/j.gastro.2020.11.001
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Patients With Inflammatory Bowel Disease Under Biologic TreatmentGastroenterology, 2020
- Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International RegistryGastroenterology, 2020
- Inflammatory Bowel Disease Management During the COVID-19 Outbreak: The Ten Do’s and Don’ts from the ECCO-COVID TaskforceJournal of Crohn's and Colitis, 2020
- Probiotics and COVID-19: one size does not fit allThe Lancet Gastroenterology & Hepatology, 2020
- Uneventful Course in Patients With Inflammatory Bowel Disease During the Severe Acute Respiratory Syndrome Coronavirus 2 Outbreak in Northern ItalyGastroenterology, 2020
- Zero COVID‐19 infection in inflammatory bowel disease patients: Findings from population‐based inflammatory bowel disease registries in Hong Kong and TaiwanJournal of Gastroenterology and Hepatology, 2020
- Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently neededThe Lancet, 2020
- Coronaviruses and Immunosuppressed Patients: The Facts During the Third EpidemicLiver Transplantation, 2020